Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -161.00% is 73% below its 5-year average of -92.93%, around the middle of its 5-year range (-285.33%–-38.05%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.40% below its 12-month average of -148.52%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
-161.00%
RETURN ON EQUITY (ROE) AVG TTM
-148.52%
RETURN ON EQUITY (ROE) AVG 3Y
-116.18%
RETURN ON EQUITY (ROE) AVG 5Y
-92.93%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-8.40%
CURRENT VS 3Y AVG
-38.58%
CURRENT VS 5Y AVG
-73.24%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
11.20%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-1537.50%
vs the sector median at left
Scholar Rock Holding Corporation
Market Cap
$6.81B
Return on Equity (ROE)
-161.00%
TTM Avg
-148.52%
3Y Avg
-116.18%
5Y Avg
-92.93%
Market Cap
$6.78B
Return on Equity (ROE)
33.11%
TTM Avg
27.03%
3Y Avg
27.48%
5Y Avg
31.41%
Market Cap
$6.60B
Return on Equity (ROE)
-43.83%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
Market Cap
$7.77B
Return on Equity (ROE)
26.84%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$5.41B
Return on Equity (ROE)
8.67%
TTM Avg
8.42%
3Y Avg
7.80%
5Y Avg
5.80%
Market Cap
$5.00B
Return on Equity (ROE)
18.24%
TTM Avg
20.62%
3Y Avg
17.32%
5Y Avg
27.02%
Market Cap
$10.04B
Return on Equity (ROE)
15.51%
TTM Avg
15.81%
3Y Avg
15.92%
5Y Avg
17.27%
Market Cap
$10.23B
Return on Equity (ROE)
12.77%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$10.30B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scholar Rock Holding Corporation (SRRK) | $6.81B | -161.00% | -148.52% | -116.18% | -92.93% |
| Chemed Corporation (CHE)vs › | $6.78B | 33.11% | 27.03% | 27.48% | 31.41% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.60B | -43.83% | 25.09% | 5.57% | 0.40% |
| Oscar Health, Inc. (OSCR)vs › | $7.77B | 26.84% | -21.41% | -36.14% | -25.75% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.41B | 8.67% | 8.42% | 7.80% | 5.80% |
| Doximity, Inc. (DOCS)vs › | $5.00B | 18.24% | 20.62% | 17.32% | 27.02% |
| The Ensign Group, Inc. (ENSG)vs › | $10.04B | 15.51% | 15.81% | 15.92% | 17.27% |
| Henry Schein, Inc. (HSIC)vs › | $10.23B | 12.77% | 11.88% | 12.69% | 13.50% |
| Insulet Corp. (PODD)vs › | $10.30B | 26.39% | 25.41% | 19.99% | 14.02% |
| Universal Health Services, Inc. (UHS)vs › | $10.31B | 20.31% | 18.80% | 15.17% | 15.31% |
ROE
-161.0%
ROA
-78.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -161.00% |
| 2026-03-31 | -148.08% |
| 2025-12-31 | -153.95% |
| 2025-09-30 | -144.26% |
| 2025-06-30 | -135.32% |
| 2025-03-31 | -84.58% |
| 2024-12-31 | -66.81% |
| 2024-09-30 | -285.33% |
| 2024-06-30 | -152.56% |
| 2024-03-31 | -100.27% |
| 2023-12-31 | -73.61% |
| 2023-09-30 | -94.78% |
| 2023-06-30 | -78.94% |
| 2023-03-31 | -72.57% |
| 2022-12-31 | -51.68% |
| 2022-09-30 | -44.72% |
| 2022-06-30 | -38.05% |
| 2022-03-31 | -65.42% |
| 2021-12-31 | -76.59% |
| 2021-09-30 | -65.39% |
| 2021-06-30 | -50.08% |
| 2021-03-31 | -40.36% |
| 2020-12-31 | -33.16% |
| 2020-09-30 | -113.51% |
| 2020-06-30 | -77.97% |
| 2020-03-31 | -58.10% |
| 2019-12-31 | -45.17% |
| 2019-09-30 | -44.66% |
| 2019-06-30 | -38.00% |
| 2019-03-31 | -52.49% |
| 2018-12-31 | -46.26% |
| 2018-09-30 | -41.84% |
| 2018-06-30 | -34.03% |
| 2018-03-31 | -61.57% |
